Association between periodontitis and anti-citrullinated protein antibodies in rheumatoid arthritis patients: a cross-sectional study
- PMID: 32054521
- PMCID: PMC7020577
- DOI: 10.1186/s13075-020-2121-6
Association between periodontitis and anti-citrullinated protein antibodies in rheumatoid arthritis patients: a cross-sectional study
Abstract
Aim: The aim of this study was to evaluate the association between periodontal parameters related with the periodontal disease severity and the presence and levels of anti-citrullinated protein antibodies (ACPAs) in rheumatoid arthritis (RA) patients.
Materials and methods: This cross-sectional study included 164 RA patients. Socio-demographics and RA disease characteristics, including ELISA-detected ACPA (anti-CCP-2), were recorded. Exposure was assessed by periodontal parameters: plaque index (PI), bleeding on probing (BoP), probing pocket depth, and clinical attachment levels (CAL). Presence and levels of ACPAs (outcome) and exposure variables were compared by both parametric and non-parametric tests and associations were evaluated by adjusted odds ratio (OR).
Results: A significant association was observed between the presence of anti-CCP antibodies and severity of periodontal outcomes such as the mean CAL (OR 1.483, p = 0.036), mean PI (OR 1.029, p = 0.012), and the number of pockets ≥ 5 mm (OR 1.021, p = 0.08). High anti-CCP antibodies levels were associated with mean CAL, mean PI, and number of pockets ≥ 5 mm with an OR of 1.593 (p = 0.043), 1.060 (p < 0.001), and 1.031 (p = 0.031), respectively. Furthermore, a significant increase of 4.45 U/mL in anti-CCP antibodies levels (p = 0.002) in RA patients was found for each pocket ≥ 5 mm after adjusting for age, gender, smoking, time of disease evolution, and RA activity.
Conclusions: In RA patients, the severity of periodontal conditions such as mean CAL, mean PI, and the number of pockets ≥ 5 mm were linearly associated with both the presence and levels of anti-CCP antibodies.
Keywords: ACPA; Rheumatoid arthritis; Rheumatoid factor; Severe periodontitis.
Conflict of interest statement
The authors declare that they have no competing interests.
Figures
Similar articles
-
Periodontal status correlates with anti-citrullinated protein antibodies in first-degree relatives of individuals with rheumatoid arthritis.J Clin Periodontol. 2019 Jul;46(7):690-698. doi: 10.1111/jcpe.13117. Epub 2019 May 28. J Clin Periodontol. 2019. PMID: 31025368
-
Association between severity of periodontitis and clinical activity in rheumatoid arthritis patients: a case-control study.Arthritis Res Ther. 2019 Jan 18;21(1):27. doi: 10.1186/s13075-019-1808-z. Arthritis Res Ther. 2019. PMID: 30658685 Free PMC article.
-
Autoantibodies against citrullinated histone H3 in rheumatoid arthritis and periodontitis patients.J Clin Periodontol. 2017 Jun;44(6):577-584. doi: 10.1111/jcpe.12727. Epub 2017 May 23. J Clin Periodontol. 2017. PMID: 28370244
-
Influence of anti-rheumatic agents on the periodontal condition of patients with rheumatoid arthritis and periodontitis: A systematic review and meta-analysis.J Periodontal Res. 2021 Dec;56(6):1099-1115. doi: 10.1111/jre.12925. Epub 2021 Sep 12. J Periodontal Res. 2021. PMID: 34514591
-
[The pathogenic role of ACPA in rheumatoid arthritis].Nihon Rinsho Meneki Gakkai Kaishi. 2017;40(6):391-395. doi: 10.2177/jsci.40.391. Nihon Rinsho Meneki Gakkai Kaishi. 2017. PMID: 29367523 Review. Japanese.
Cited by
-
Treatment resistance of rheumatoid arthritis relates to infection of periodontal pathogenic bacteria: a case-control cross-sectional study.Sci Rep. 2022 Jul 19;12(1):12353. doi: 10.1038/s41598-022-16279-z. Sci Rep. 2022. PMID: 35854051 Free PMC article.
-
Rheumatoid arthritis serotype and synthetic disease-modifying anti-rheumatic drugs in patients with periodontitis: A case-control study.PLoS One. 2021 Jun 21;16(6):e0252859. doi: 10.1371/journal.pone.0252859. eCollection 2021. PLoS One. 2021. PMID: 34153036 Free PMC article.
-
The development of anticyclic citrullinated peptide (anti-CCP) antibody following severe COVID-19.Immun Inflamm Dis. 2024 May;12(5):e1276. doi: 10.1002/iid3.1276. Immun Inflamm Dis. 2024. PMID: 38780036 Free PMC article.
-
The Role of Methyl Canthin-6-one-2-carboxylate in Targeting the NLRP3 Inflammasome in Rheumatoid Arthritis Treatment.Curr Issues Mol Biol. 2025 Apr 7;47(4):254. doi: 10.3390/cimb47040254. Curr Issues Mol Biol. 2025. PMID: 40699653 Free PMC article. Review.
-
Oral Infections and Systemic Health - More than Just Links to Cardiovascular Diseases.Oral Health Prev Dent. 2021 Sep 11;19:441-448. doi: 10.3290/j.ohpd.b1993965. Oral Health Prev Dent. 2021. PMID: 34505498 Free PMC article. Review.
References
-
- Rakieh C, Rakieh C, Nam JL, Nam JL, Hunt L, Hunt L, et al. Predicting the development of clinical arthritis in anti-CCP positive individuals with non-specific musculoskeletal symptoms: a prospective observational cohort study. Ann Rheum Dis. 2015;74:1659–1666. doi: 10.1136/annrheumdis-2014-205227. - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous